Safety and effects of a once-weekly, long-acting release formulation of exenatide over 15 weeks in patients with type 2 diabetes

被引：0
|
作者：
Maggs, D.
MacConell, L.
Zhuang, D.
Schnabel, C.
Taylor, K.
Trautmann, M.
Kim, D.
机构：
[1] Amylin Pharmaceut Inc, San Diego, CA USA
[2] Lilly Forsch GmbH, Hamburg, Germany
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0002
引用
下载
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [1] Safety and effects of a once-weekly, long-acting release formulation of exenatide over 15 weeks in patients with type 2 diabetes
    Kim, Dennis
    MaCconell, Leigh
    Zhuang, Dongliang
    Schnabel, Catherine
    Taylor, Kristin
    Li, Wen-I
    Trautmann, Michael
    DIABETES, 2006, 55 : A116 - A116
  • [2] Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes
    Kim, Dennis
    MacConell, Leigh
    Zhuang, Dongliang
    Kothare, Prajakti A.
    Trautmann, Michael
    Fineman, Mark
    Taylor, Kristin
    DIABETES CARE, 2007, 30 (06) : 1487 - 1493
  • [3] Once-weekly exenatide in type 2 diabetes
    Dinesh M. Parmar
    Shilpa P. Jadav
    International Journal of Diabetes in Developing Countries, 2011, 31 : 121 - 122
  • [4] Once-weekly exenatide in type 2 diabetes
    Parmar, Dinesh M.
    Jadav, Shilpa P.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2011, 31 (02) : 121 - 122
  • [5] Exenatide extended-release: A once-weekly option for patients with type 2 diabetes
    Anderson, Zachary L.
    Clements, Jennifer N.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2014, 27 (06): : 44 - 46
  • [6] Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks
    Diamant, Michaela
    Van Gaal, Luc
    Stranks, Stephen
    Guerci, Bruno
    MacConell, Leigh
    Haber, Harry
    Scism-Bacon, Jamie
    Trautmann, Michael
    DIABETES CARE, 2012, 35 (04) : 683 - 689
  • [7] Once-Weekly Exenatide in Youth With Type 2 Diabetes
    Tamborlane, William, V
    Bishai, Raafat
    Geller, David
    Shehadeh, Naim
    Al-Abdulrazzaq, Dalia
    Manica Vazquez, Evelina
    Karoly, Eva
    Troja, Tunde
    Doehring, Orlando
    Carter, Debra
    Monyak, John
    Sjostrom, C. David
    DIABETES CARE, 2022, 45 (08) : 1833 - 1840
  • [8] Once-weekly exenatide as a treatment for Type 2 diabetes
    Schauerhamer, Marisa B.
    Gurgle, Holly
    McAdam-Marx, Carrie
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (06) : 611 - 626
  • [9] Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
    Holman, Rury R.
    Bethel, M. Angelyn
    Mentz, Robert J.
    Thompson, Vivian P.
    Lokhnygina, Yuliya
    Buse, John B.
    Chan, Juliana C.
    Choi, Jasmine
    Gustavson, Stephanie M.
    Iqbal, Nayyar
    Maggioni, Aldo P.
    Marso, Steven P.
    Ohman, Peter
    Pagidipati, Neha J.
    Poulter, Neil
    Ramachandran, Ambady
    Zinman, Bernard
    Hernandez, Adrian F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (13): : 1228 - 1239
  • [10] Emerging utility of once-weekly exenatide in patients with type 2 diabetes
    Goud, Aditya
    Zhong, Jixin
    Rajagopalan, Sanjay
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2015, 8 : 505 - 512
12345